We mainly elucidate the role of S100A9 in modulating inflammatory responses, amplifying tissue fibrosis, promoting vascular calcification, inducing endothelial dysfunction, and serving as a pivotal biomarker in inflammation‐associated CVD. Here, S100A9 is linked to endothelial dysfunction.